These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39041067)

  • 1. Discovery of Potent and Selective G9a Degraders for the Treatment of Pancreatic Cancer.
    Shi Y; Shen Q; Long R; Mao Y; Tong S; Yang Y; Gao J; Zhou H; Chen Y; Zhou B
    J Med Chem; 2024 Aug; 67(15):13271-13285. PubMed ID: 39041067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of the First-in-Class G9a/GLP PROTAC Degrader.
    Velez J; Han Y; Yim H; Yang P; Deng Z; Park KS; Kabir M; Kaniskan HÜ; Xiong Y; Jin J
    J Med Chem; 2024 Apr; 67(8):6397-6409. PubMed ID: 38602846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.
    Liu F; Barsyte-Lovejoy D; Li F; Xiong Y; Korboukh V; Huang XP; Allali-Hassani A; Janzen WP; Roth BL; Frye SV; Arrowsmith CH; Brown PJ; Vedadi M; Jin J
    J Med Chem; 2013 Nov; 56(21):8931-42. PubMed ID: 24102134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a Highly Potent Lysine Methyltransferases G9a/NSD2 Dual Inhibitor to Treat Solid Tumors.
    Yang C; Li B; Feng Z; Li H; Yang H; Yang Z; Liu L; Shi Q; Wang H; Chen ZZ; Huang X; Wang J; Wang Y
    J Med Chem; 2024 Sep; 67(18):16072-16087. PubMed ID: 39008565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting H3K9 methyltransferase G9a and its related molecule GLP as a potential therapeutic strategy for cancer.
    Rahman Z; Bazaz MR; Devabattula G; Khan MA; Godugu C
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22674. PubMed ID: 33283949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma.
    Yuan Y; Wang Q; Paulk J; Kubicek S; Kemp MM; Adams DJ; Shamji AF; Wagner BK; Schreiber SL
    ACS Chem Biol; 2012 Jul; 7(7):1152-7. PubMed ID: 22536950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
    Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
    Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery, design and synthesis of 6H-anthra[1,9-cd]isoxazol-6-one scaffold as G9a inhibitor through a combination of shape-based virtual screening and structure-based molecular modification.
    Chen WL; Wang ZH; Feng TT; Li DD; Wang CH; Xu XL; Zhang XJ; You QD; Guo XK
    Bioorg Med Chem; 2016 Nov; 24(22):6102-6108. PubMed ID: 27720557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis.
    Kato H; Tateishi K; Fujiwara H; Ijichi H; Yamamoto K; Nakatsuka T; Kakiuchi M; Sano M; Kudo Y; Hayakawa Y; Nakagawa H; Tanaka Y; Otsuka M; Hirata Y; Tachibana M; Shinkai Y; Koike K
    Cancer Genomics Proteomics; 2020; 17(6):695-705. PubMed ID: 33099471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS
    Wang X; Allen S; Blake JF; Bowcut V; Briere DM; Calinisan A; Dahlke JR; Fell JB; Fischer JP; Gunn RJ; Hallin J; Laguer J; Lawson JD; Medwid J; Newhouse B; Nguyen P; O'Leary JM; Olson P; Pajk S; Rahbaek L; Rodriguez M; Smith CR; Tang TP; Thomas NC; Vanderpool D; Vigers GP; Christensen JG; Marx MA
    J Med Chem; 2022 Feb; 65(4):3123-3133. PubMed ID: 34889605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines.
    Katayama K; Ishii K; Tsuda E; Yotsumoto K; Hiramoto K; Suzuki M; Yasumatsu I; Igarashi W; Torihata M; Ishiyama T; Katagiri T
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127475. PubMed ID: 32781218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of benzimidazole derivatives as the G9a Histone Methyltransferase inhibitors that induce autophagy and apoptosis of breast cancer cells.
    Zhang J; Yao D; Jiang Y; Huang J; Yang S; Wang J
    Bioorg Chem; 2017 Jun; 72():168-181. PubMed ID: 28460359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents.
    Cao H; Li L; Yang D; Zeng L; Yewei X; Yu B; Liao G; Chen J
    Eur J Med Chem; 2019 Oct; 179():537-546. PubMed ID: 31276898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines.
    Liu F; Chen X; Allali-Hassani A; Quinn AM; Wigle TJ; Wasney GA; Dong A; Senisterra G; Chau I; Siarheyeva A; Norris JL; Kireev DB; Jadhav A; Herold JM; Janzen WP; Arrowsmith CH; Frye SV; Brown PJ; Simeonov A; Vedadi M; Jin J
    J Med Chem; 2010 Aug; 53(15):5844-57. PubMed ID: 20614940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights for the design of protein lysine methyltransferase G9a inhibitors.
    Charles MRC; Dhayalan A; Hsieh HP; Coumar MS
    Future Med Chem; 2019 May; 11(9):993-1014. PubMed ID: 31141392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
    Lin X; Huang Y; Zou Y; Chen X; Ma X
    Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of the First-in-class G9a/GLP PROTAC Degrader.
    Velez J; Han Y; Yim H; Yang P; Deng Z; Park KS; Kabir M; Kaniskan HÜ; Xiong Y; Jin J
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G9a - An Appealing Antineoplastic Target.
    Chen WL; Sun HP; Li DD; Wang ZH; You QD; Guo XK
    Curr Cancer Drug Targets; 2017; 17(6):555-568. PubMed ID: 27174055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zinc finger proteins ZNF644 and WIZ regulate the G9a/GLP complex for gene repression.
    Bian C; Chen Q; Yu X
    Elife; 2015 Mar; 4():. PubMed ID: 25789554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with
    Rabal O; San José-Enériz E; Agirre X; Sánchez-Arias JA; de Miguel I; Ordoñez R; Garate L; Miranda E; Sáez E; Vilas-Zornoza A; Pineda-Lucena A; Estella A; Zhang F; Wu W; Xu M; Prosper F; Oyarzabal J
    J Med Chem; 2021 Mar; 64(6):3392-3426. PubMed ID: 33661013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.